{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:08:54Z","timestamp":1778400534753,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473063"],"award-info":[{"award-number":["82473063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172348"],"award-info":[{"award-number":["82172348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC3602301"],"award-info":[{"award-number":["2022YFC3602301"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC3602300"],"award-info":[{"award-number":["2022YFC3602300"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC3602302"],"award-info":[{"award-number":["2022YFC3602302"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clinbiochem.2026.111120","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:07:48Z","timestamp":1774310868000},"page":"111120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Validation and optimization of reference intervals for serum free light chains in Chinese patients with chronic kidney disease"],"prefix":"10.1016","volume":"143","author":[{"given":"Wen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.clinbiochem.2026.111120_b0005","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"136","author":"Palladini","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111120_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-020-0319-0","article-title":"The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?","volume":"10","author":"Sidiqi","year":"2020","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0015","doi-asserted-by":"crossref","unstructured":"Caillon, HeleneAvet-Loiseau, HerveAttal, MichelMoreau, PhilippeDecaux, OlivierDejoie, Thomas. Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma. Clinical lymphoma, myeloma & Leukemia, 2019, 19(5).","DOI":"10.1016\/j.clml.2019.01.007"},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111120_b0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1515\/CCLM.2010.283","article-title":"Detection of serum free light chains: the problem with antigen excess","volume":"48","author":"Bosmann","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2026.111120_b0030","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/cei.12011","article-title":"Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma","volume":"171","author":"Murng","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111120_b0040","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1515\/cclm-2024-0923","article-title":"Serum free light chains reference intervals in the Lebanese","volume":"63","author":"El Karaaoui","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111120_b0045","first-page":"193","article-title":"Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population","volume":"60","author":"Liang","year":"2014","journal-title":"Clin. Lab."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0050","article-title":"Reference intervals for free light chains in Saudi adults","author":"Borai","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0055","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111120_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0065","doi-asserted-by":"crossref","unstructured":"Luis J Morales-Garc\u00eda, Rosa M. Lillo Rodr\u00edguez, Mar\u00eda S Pacheco-Delgado. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment. Clin. Biochem., 2023: 110610. DOI:10.1016\/j.clinbiochem.2023.110610].","DOI":"10.1016\/j.clinbiochem.2023.110610"},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111120_b0070","first-page":"1027","article-title":"Impact of chronic kidney disease on free light chain assay in multiple myeloma","volume":"30","author":"Mackay","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111120_b0075","first-page":"348","article-title":"Establishment of medical reference ranges of serum free light chain ratio in Shanghai population and its diagnostic value on PCN","volume":"24","author":"Chen","year":"2017","journal-title":"Chin J Clin Med"},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111120_b0080","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic18 kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111120_b0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.13156","article-title":"Guidelines on the diagnosis and investigation of AL amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111120_b0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"Anewequationto estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clinbiochem.2026.111120_b0095","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"10.1016\/j.clinbiochem.2026.111120_b0100","unstructured":"Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline: Third Edition. CLSI Document EP28-A3c. Wayne, PA: Clinical and Laboratory Standards Institute, 2010. https:\/\/www.clsi.org\/."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111120_b0105","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1172\/JCI107023","article-title":"The renal handling of low molecular weight proteins: ii. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia","volume":"51","author":"Waldmann","year":"1972","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111120_b0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41408-022-00732-3","article-title":"Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study","volume":"12","author":"Long","year":"2022","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111120_b0115","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1515\/cclm-2024-1226","article-title":"Assessment of serum free light chain measurements in a large Chinese chronic kidney disease cohort: a multicenter real-world study","volume":"63","author":"Luo","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111120_b0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/1024533212Z.000000000146","article-title":"Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa\/lambda ratio of cd38-positive plasma cells","volume":"17","author":"Nakayama","year":"2012","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111120_b0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0009-8981(67)90036-8","article-title":"Effect of impaired hepatic and renal function on Bence Jones protein catabolism in human subjects","volume":"18","author":"Miettinen","year":"1967","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.clinbiochem.2026.111120_b0130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ki.2011.94","article-title":"The biology of immunoglobulin free light chains and kidney injury","volume":"79","author":"Stringer","year":"2011","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111120_b0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2141.2008.07522.x","article-title":"Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease","volume":"144","author":"Kaplan","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111120_b0140","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2018-0412","article-title":"Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent .Clinical chemistry and laboratory medicine","volume":"57","author":"Caponi","year":"2019","journal-title":"CCLM"},{"key":"10.1016\/j.clinbiochem.2026.111120_b0145","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2018-0994","article-title":"Response to article by caponi et al. About serum free light chains","volume":"57","author":"Tate","year":"2018","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111120_b0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jalm.2019.029330","article-title":"Serum free light chain assay: shift toward a higher \u03ba\/\u03bb ratio","volume":"5","author":"Rindlisbacher","year":"2020","journal-title":"J. Appl. Lab. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:48:50Z","timestamp":1778399330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S0009912026000482"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111120","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and optimization of reference intervals for serum free light chains in Chinese patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111120"}}